scholarly journals Deep2Full: Predictive model for complementing phenotypic outcomes in a deep mutational scan using protein sequence and structure information

2017 ◽  
Author(s):  
C. K. Sruthi ◽  
Meher K. Prakash

AbstractLarge scale mutagenesis experiments are becoming possible owing to the advancement in the sequencing technologies and high throughput screening. Deep mutational scans perform exhaustive single-point muta-tions on a protein and probe their phenotypic effects. Performing a full scan with site-directed mutations of all the amino acid residues in a protein may not be practical, and may not even be required, especially if predictive computational models can be developed. Computational models are however naive to cellular response in the myriads of assay-conditions. In order to develop the realistic paradigm of assay context-aware predictive hybrid models, we combine minimal deep mutational studies with computational models and pre-dict the phenotypic outcomes quantitatively. Structural, sequence and co-evolutionary information along with partial deep mutational scan data was included to capture the phenotypic relevance of the mutations to the specific screening criterion. The model reliably predicts the fitness outcomes of hundreds of randomly selected amino acid mutations in β-lactamase, when the phenotypic fitness data from as few as 15% of the full mutation is available. Interestingly, the predictive capabilities are better with a random set of mutations rather than with a systematic substitution of all amino acids to alanine, asparagine and histidine (ANH). The model can potentially be extended for predicting the phenotypic outcomes at other concentrations of the stressor by carefully analyzing the dose-response curves of a representative set of mutations.Author SummaryMutations are the minor changes in protein sequences, with incommensurately high consequences for their function. Many severe diseases can occur with simple single point mutations. An interesting way of studying these mutations is not to isolate the protein from its natural conditions, but rather study how the fitness of the cell improves or decreases in response to these mutations. Whether it is for understanding disease biology or for bio-engineering applications it is important to quantify the impact of mutations on the cellular fitness. An experimental paradigm has evolved which has improved the ability to sample several hundred thousands of mutation-fitness relations using high throughput screening. However, since these are very specialized experiments, the question is if the number of such experiments required can be minimized, by using computer models to complement the rest of the fitness predictions. In this work we introduce this new paradigm which uses computer model trained on a partial deep mutation scan data, to predict the fitness variations in a full mutations scan that could also be repeated under multiple experimental conditions like drug concentrations.

Author(s):  
Ajay Iyer ◽  
Lisa Guerrier ◽  
Salomé Leveque ◽  
Charles S. Bestwick ◽  
Sylvia H. Duncan ◽  
...  

AbstractInvasive plants offer an interesting and unconventional source of protein and the considerable investment made towards their eradication can potentially be salvaged through their revalorisation. To identify viable sources, effective and high-throughput screening methods are required, as well as efficient procedures to isolate these components. Rigorous assessment of low-cost, high-throughput screening assays for total sugar, phenolics and protein was performed, and ninhydrin, Lever and Fast Blue assays were found to be most suitable owing to high reliability scores and false positive errors less than 1%. These assays were used to characterise invasive Scottish plants such as Gorse (Ulex europeans), Broom (Cystisus scoparius) and Fireweed (Chamaenerion angustifolium). Protein extraction (alkali-, heat- and enzyme assisted) were tested on these plants, and further purification (acid and ethanol precipitation, as well as ultrafiltration) procedures were tested on Gorse, based on protein recovery values. Cellulase treatment and ethanol precipitation gave the highest protein recovery (64.0 ± 0.5%) and purity (96.8 ± 0.1%) with Gorse. The amino acid profile of the purified protein revealed high levels of essential amino acids (34.8 ± 0.0%). Comparison of results with preceding literature revealed a strong association between amino acid profiles and overall protein recovery with the extraction method employed. The final purity of the protein concentrates was closely associated to the protein content of the initial plant mass. Leaf protein extraction technology can effectively raise crop harvest indices, revalorise underutilised plants and waste streams.


Lab on a Chip ◽  
2021 ◽  
Author(s):  
Xing Zhao ◽  
Gaozhi Ou ◽  
Mengcheng Lei ◽  
Yang Zhang ◽  
Lina Li ◽  
...  

Cells in native microenvironment are subjected to varying combinations of biochemical cues and mechanical cues in a wide range. Despite many signaling pathways have been found to be responsive for...


2008 ◽  
Vol 13 (10) ◽  
pp. 999-1006 ◽  
Author(s):  
Caroline Engeloch ◽  
Ulrich Schopfer ◽  
Ingo Muckenschnabel ◽  
Francois Le Goff ◽  
Hervé Mees ◽  
...  

The impact of storage conditions on compound stability and compound solubility has been debated intensely over the past 5 years. At Novartis, the authors decided to opt for a storage concept that can be considered controversial because they are using a DMSO/water (90/10) mixture as standard solvent. To assess the effect of water in DMSO stocks on compound stability, the authors monitored the purity of a subset of 1404 compounds from ongoing medicinal chemistry projects over several months. The study demonstrated that 85% of the compounds were stable in wet DMSO over a 2-year period at 4 °C. This result validates the storage concept developed at Novartis as a pragmatic approach that takes advantage of the benefits of DMSO/water mixtures while mediating the disadvantages. In addition, the authors describe how purity data collected over the course of the chemical validation of high-throughput screening actives are used to improve the analytical quality of the Novartis screening deck. ( Journal of Biomolecular Screening 2008:999-1006)


2012 ◽  
Vol 17 (4) ◽  
pp. 519-529 ◽  
Author(s):  
Michael Prummer

Following the success of small-molecule high-throughput screening (HTS) in drug discovery, other large-scale screening techniques are currently revolutionizing the biological sciences. Powerful new statistical tools have been developed to analyze the vast amounts of data in DNA chip studies, but have not yet found their way into compound screening. In HTS, characterization of single-point hit lists is often done only in retrospect after the results of confirmation experiments are available. However, for prioritization, for optimal use of resources, for quality control, and for comparison of screens it would be extremely valuable to predict the rates of false positives and false negatives directly from the primary screening results. Making full use of the available information about compounds and controls contained in HTS results and replicated pilot runs, the Z score and from it the p value can be estimated for each measurement. Based on this consideration, we have applied the concept of p-value distribution analysis (PVDA), which was originally developed for gene expression studies, to HTS data. PVDA allowed prediction of all relevant error rates as well as the rate of true inactives, and excellent agreement with confirmation experiments was found.


Lab on a Chip ◽  
2010 ◽  
Vol 10 (2) ◽  
pp. 227-234 ◽  
Author(s):  
Christopher Moraes ◽  
Jan-Hung Chen ◽  
Yu Sun ◽  
Craig A. Simmons

2006 ◽  
Vol 11 (5) ◽  
pp. 481-487 ◽  
Author(s):  
Philip E. Brandish ◽  
Chi-Sung Chiu ◽  
Jonathan Schneeweis ◽  
Nicholas J. Brandon ◽  
Clare L. Leech ◽  
...  

Enzymes are often considered less “druggable” targets than ligand-regulated proteins such as G-protein-coupled receptors, ion channels, or other hormone receptors. Reasons for this include cellular location (intracellular vs. cell surface), typically lower affinities for the binding of small molecules compared to ligand-specific receptors, and binding (catalytic) sites that are often charged or highly polar. A practical drawback to the discovery of compounds targeting enzymes is that screening of compound libraries is typically carried out in cell-free activity assays using purified protein in an inherently artificial environment. Cell-based assays, although often arduous to design for enzyme targets, are the preferred discovery tool for the screening of large compound libraries. The authors have recently described a novel cell-based approach to screening for inhibitors of a phosphatase enzyme and now report on the development and implementation of a homogeneous 3456-well plate assay for D-amino acid oxidase (DAO). Human DAO was stably expressed in Chinese hamster ovary (CHO) cells, and its activity was measured as the amount of hydrogen peroxide detected in the growth medium following feeding the cells with D-serine. In less than 12 weeks, the authors proved the concept in 96-and then 384-well formats, miniaturized the assay to the 3456-well (nanoplate) scale, and screened a library containing more than 1 million compounds. They have identified several cell-permeable inhibitors of DAO from this cell-based high-throughput screening, which provided the discovery program with a few novel and attractive lead structures.


Sign in / Sign up

Export Citation Format

Share Document